GSA Capital Partners’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-66,396	Closed	-$81K	–	1882
2025 Q1	$81K	Buy	66,396 +44,862	+208%	+$54.7K	0.01%	1523
2024 Q4	$28K	Buy	+21,534	New	+$28K	﹤0.01%	1551
2019 Q2	–	Sell	-56,915	Closed	-$291K	–	1536
2019 Q1	$291K	Buy	+56,915	New	+$291K	0.03%	1005